Pepcid vs. Pantoprazole

See how Pepcid and Pantoprazole compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Pepcid is an H2 blocker that starts working within about an hour, while pantoprazole is a PPI that can take a few days to reach full effect.

  • Pantoprazole gives longer-lasting acid suppression and higher healing rates for erosive esophagitis, but it needs a prescription in the U.S.

  • Pepcid is sold over the counter at lower doses, so it is easier to access for occasional heartburn without seeing a doctor first.

Pepcid vs. Pantoprazole Drug Summary

Pepcid

Pepcid (famotidine) is a histamine-2 (H2) blocker that reduces stomach acid production. It treats heartburn, GERD, ulcers, and erosive esophagitis, and is taken as a tablet once or twice daily depending on the condition.

Pantoprazole

Pantoprazole is a proton pump inhibitor (PPI) that blocks the stomach's acid pump for longer-lasting relief. It treats erosive esophagitis from GERD and Zollinger-Ellison syndrome, taken as a delayed-release tablet once or twice daily.

Pepcid vs. Pantoprazole Side Effects

Pepcid

Most common
Headache (up to 4.7%)
Diarrhea (up to 1.7%)
Dizziness (up to 1.3%)
Constipation (up to 1.2%)

Pantoprazole

Most common
Headache (up to 12.2%)
Diarrhea (up to 8.8%)
Nausea (up to 7%)
Abdominal pain (up to 6.2%)

Pepcid vs. Pantoprazole Dosage

Pepcid

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 40 mg once daily At the start
Maximum dose 20 mg once daily If needed
Dose changes 3 increases As tolerated

Pantoprazole

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 40 mg once daily Weeks 1-8
Maximum dose 40 mg twice daily If needed
Dose changes 1 increase As tolerated

Pepcid vs. Pantoprazole Indications

Pepcid

Pepcid is FDA-approved for short-term treatment of active duodenal and gastric ulcers, GERD, and erosive esophagitis, plus maintenance therapy for healed ulcers. It also treats pathological hypersecretory conditions such as Zollinger-Ellison syndrome.

  • Active duodenal ulcer (up to 8 weeks)

  • GERD (up to 6 weeks)

  • Erosive esophagitis (up to 12 weeks)

  • Pathological hypersecretory conditions

Pantoprazole

Pantoprazole is FDA-approved for short-term treatment of erosive esophagitis caused by GERD and for maintenance therapy once it has healed. It also treats pathological hypersecretory conditions like Zollinger-Ellison syndrome, but it is not approved for immediate heartburn relief.

  • Erosive esophagitis from GERD (short-term)

  • Maintenance of healed erosive esophagitis

  • Pathological hypersecretory conditions

  • Approved for pediatric use (age 5+)

Pepcid vs. Pantoprazole Pros and Cons

Pepcid

Pepcid has a well-established safety profile, a fast onset within about an hour, and is available over the counter at lower doses. It is generally less potent than a PPI, so it may not fully control severe or long-standing acid damage.

Pros

  • Starts working within about an hour

  • Available over the counter at lower doses

  • Fewer long-term risks with extended use

  • Simple once- or twice-daily dosing

Cons

  • Less potent acid suppression than a PPI

  • Shorter duration of action, about 12 hours

  • Lower healing rates for erosive esophagitis

  • Effects can lessen with regular long-term use

Pantoprazole

Pantoprazole provides stronger, longer-lasting acid suppression and higher healing rates for erosive esophagitis than an H2 blocker. It requires a prescription and carries added risks with extended use.

Pros

  • Stronger, more complete acid suppression

  • Acid control lasts up to 24 hours per dose

  • Higher healing rates for erosive esophagitis

  • Available as tablet, suspension, or IV

Cons

  • Requires a prescription in the U.S.

  • Can take several days for full symptom relief

  • Long-term use linked to fracture and B12 risks

  • Not intended for on-demand heartburn relief

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.